| 李去病 刘树松 李森.痛灵止胶囊治疗癌性疼痛临床观察[J].实用中西医结合临床,2010,(4):11-12 |
| 痛灵止胶囊治疗癌性疼痛临床观察 |
|
| |
| DOI： |
| 中文关键词: 痛灵止胶囊 癌性疼痛 气滞血瘀型 中医药疗法 |
| 英文关键词: Tonglingzhi capsule Cancer pain Syndrome of Qi stagnation blood stasis Chinese medicine treatment |
| 基金项目: |
|
| 摘要点击次数: 626 |
| 全文下载次数: 255 |
| 中文摘要: |
| 目的：观察验证痛灵止胶囊对癌性疼痛缓解的临床有效性及安全性。方法：采用随机、平行对照实验方法，将癌性疼痛（气滞血瘀型）患者200例随机分为两组，每组100例。结果：中医证候疗效分析，实验组愈显率为76.00%，对照组愈显率为54.00%，两组比较有统计学意义（P <0.05）。实验组改善疼痛症状明显优于对照组（P < 0.05）,改善善太息、脉络瘀血、癥积等症状、体征两组无明显差异（P >0.05）。两组中医证候积分治疗后组内、组间比较均有统计学意义（P <0.05）。结论：痛灵止胶囊治疗癌性疼痛（气滞血瘀型）疗效确切，疗效优于天蟾胶囊，安全性较好，无明显不良反应。 |
| 英文摘要: |
| Objective:To observe and verify clinical efficacy and safety of Tonglingzhi capsule on cancer pain relief.Methods:Randomized, parallel controlled trials were designed for comparative study of 200 patients with cancer pain syndrome ( Qi stagnation blood stasis syndrome), 100 patients in each group. Results: The efficacy of traditional Chinese medicine symptom analysis, the experimental group markedly effective rate was 76.00%,the control group was 54.00%,the two groups was statistically significant (P < 0.05).Experimental group mitigated the pain much better than the control group(P <0.05).To improved Shantaixi、vein congestion、disease product symptoms and signs showed no significant difference between the two groups(P >0.05).Two groups after treatment of TCM，comparisons in group and between groups were statistically significant(P <0.05).Conclusion:Tonglingzhi capsule has significant curative effect on treatment of cancer pain syndrome, efficacy is superior to Tianchan capsule, security and no obvious adverse reactions. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
